|
 |
|
|
|
|
7. A. Ensminger et al., Foods & Nutrition Encyclopedia, 2d ed. (Boca Raton, Fla.: CRC Press, 1994), 319-24. |
|
|
|
 |
|
|
|
|
8. D. Forman et al., "Cancer of the Liver and the Use of Oral Contraceptives," British Medical Journal 292: 1357-61 (1986). |
|
|
|
 |
|
|
|
|
9. N.C. Lee et al., "A Case-control Study of Breast Cancer and Hormonal Contraception in Costa Rica," Journal of the National Cancer Institute 79 (6): 1247-54 (1987). |
|
|
|
 |
|
|
|
|
10. C. Paul et al., "Depo Medroxyprogesterone (Depo-Provera) and Risk of Breast Cancer," British Medical Journal 299 (6702): 759-62 (1989). |
|
|
|
 |
|
|
|
|
11. L. Bergkvist et al., "The Risk of Breast Cancer After Estrogen and Estrogen-Progestin Replacement," New England Journal of Medicine 321 (5): 293-7 (1989). |
|
|
|
 |
|
|
|
|
12. X.Q. Shan et al., "Glutathione-Dependent Protection Against Oxidative Injury," Pharmacology Therapeutics 47 (1): 61-71 (1990). |
|
|
|
 |
|
|
|
|
13. G. Olenschager et al., "Reduced Glutathione and Anthocyans: Redox Cycling and Redox Recycling in Living Systems," Praxis-Telegramm 6: 1-20. |
|
|
|
 |
|
|
|
|
14. S. Cascinu et al., "Neuroprotective Effect of Reduced Glutathione on Cisplatin-based Chemotherapy in Advanced Gastric Cancer: A Randomized Double-Blind Placebo-Controlled Trial," Journal of Clinical Oncology 13 (1): 26-32 (1995). |
|
|
|
 |
|
|
|
|
15. J.F. Smyth et al., "Glutathione Reduces the Toxicity and Improves Quality of Life of Women Diagnosed with Ovarian Cancer Treated with Cisplatin: Results of a Double-Blind, Randomised Trial," Annals of Oncology 8 (6): 569-73 (1997). |
|
|
|
 |
|
|
|
|
16. T.M. Hagen et al., "Glutathione Uptake and Protection Against Oxidative Injury in Isolated Kidney Cells," Kidney International 34 (1): 74-81 (1988). |
|
|
|
 |
|
|
|
|
17. K.J. Pienta et al., "Inhibition of Spontaneous Metastasis in a Rat Prostate Cancer Model by Oral Administration of Modified Citrus Pectin," Journal of the National Cancer Institute 87 (5): 348-53 (1995). |
|
|
|
 |
|
|
|
|
18. H.I. Robins et al., "Cytotoxic Interactions of Tumor Necrosis Factor, Melphalan and 41.8 Degrees C Hyperthermia," Cancer Letters 89 (1): 55-62 (1995). |
|
|
|
 |
|
|
|
|
19. I.B. Shchepotin, "Hyperthermia and Verapamil Inhibit the Growth of Human Colon Cancer Xenografts in Vivo Through Apoptosis," Anticancer Research 17 (3C): 2213-16 (1997). |
|
|
|
|
|